Immature platelet fraction in cardiovascular diagnostics and antiplatelet therapy monitoring

被引:5
作者
Gumiezna, Karolina [1 ]
Barus, Piotr [1 ]
Sygitowicz, Grazyna [2 ]
Wisniewska, Agnieszka [3 ]
Ochijewicz, Dorota [1 ]
Pasierb, Karolina [1 ]
Klimczak-Tomaniak, Dominika [4 ,5 ]
Kuca-Warnawin, Ewa [6 ]
Kochman, Janusz [1 ]
Grabowski, Marcin [1 ]
Opolski, Grzegorz [1 ]
Tomaniak, Mariusz [1 ,7 ]
Filipiak, Krzysztof J. [1 ]
机构
[1] Med Univ Warsaw, Dept Cardiol 1, Warsaw, Poland
[2] Med Univ Warsaw, Dept Clin Chem & Lab Diagnost, Warsaw, Poland
[3] Med Univ Warsaw, Dept Lab Diagnost, Warsaw, Poland
[4] Med Univ Warsaw, Dept Cardiol Hypertens & Internal Med, Warsaw, Poland
[5] Med Univ Warsaw, Dept Immunol Transplantat & Internal Med, Warsaw, Poland
[6] Natl Inst Geriatr Rheumatol & Rehabil, Dept Pathophysiol & Immunol, Warsaw, Poland
[7] Med Univ Warsaw, Dept Cardiol 1, Ul Banacha 1a, PL-02097 Warsaw, Poland
关键词
immature platelet fraction; antiplatelet therapy monitoring; acute coronary syndromes; CORONARY-ARTERY-DISEASE; RETICULATED PLATELETS; STENT THROMBOSIS; INFARCT SIZE; TURNOVER; VOLUME; AGGREGATION; PREDICTORS; REACTIVITY; ASPIRIN;
D O I
10.5603/CJ.a2023.0019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immature platelet fraction (IPF), circulating platelets still containing RNA, can be easily calculated by automated flow cytometry, this makes them an accessible biomarker. Higher IPF concentrations were reported in patients with thrombocytopenia, patients who were smokers, and also those who were diabetics. Several studies have reported their diagnostic and prognostic importance in patients presenting with acute coronary syndromes, especially ST-segment elevation myocardial infarction, where increased IPF level is an independent predictor of cardiovascular death. In addition, higher IPF were reported in patients with inadequate response to either clopidogrel or prasugrel, suggesting their potential role in antiplatelet therapy monitoring. Their prognostic significance was also observed in both coronary artery disease and postcardiac surgery status, where their higher levels correlated with the risk of major adverse cardiac events.The current review aims to present the current evidence on diagnostic, prognostic and potentially therapeutic roles of IPF in cardiovascular medicine. (Cardiol J 2023; 30, 5: 817-824)
引用
收藏
页码:817 / 824
页数:8
相关论文
共 43 条
[1]   Immature platelets as a novel biomarker for adverse cardiovascular events in patients after non-cardiac surgery [J].
Anetsberger, Aida ;
Blobner, Manfred ;
HaIler, Bernhard ;
Schmid, Sebastian ;
Umgelter, Katrin ;
Hager, Theresa ;
Langgartner, Clemens ;
Kochs, Eberhard F. ;
Laugwitz, Karl-Ludwig ;
Jungwirth, Bettina ;
Bernlochner, Isabel .
THROMBOSIS AND HAEMOSTASIS, 2017, 117 (10) :1887-1895
[2]   THE SIGNIFICANCE OF PLATELETS WITH INCREASED RNA-CONTENT (RETICULATED PLATELETS) - A MEASURE OF THE RATE OF THROMBOPOIESIS [J].
AULT, KA ;
RINDER, HM ;
MITCHELL, J ;
CARMODY, MB ;
VARY, CPH ;
HILLMAN, RS .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1992, 98 (06) :637-646
[3]   Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome [J].
Bernlochner, Isabell ;
Goedel, Alexander ;
Plischke, Conny ;
Schuepke, Stefanie ;
Haller, Bernhard ;
Schulz, Christoph ;
Mayer, Katharina ;
Morath, Tanja ;
Braun, Siegmund ;
Schunkert, Heribert ;
Siess, Wolfgang ;
Kastrati, Adnan ;
Laugwitz, Karl-Ludwig .
EUROPEAN HEART JOURNAL, 2015, 36 (45) :3202-3210
[4]   Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54 [J].
Bonaca, Marc P. ;
Bhatt, Deepak L. ;
Steg, P. Gabriel ;
Storey, Robert F. ;
Cohen, Marc ;
Im, Kyungah ;
Ophuis, Ton Oude ;
Budaj, Andrej ;
Goto, Shinya ;
Lopez-Sendon, Jose ;
Diaz, Rafael ;
Dalby, Anthony ;
Van de Werf, Frans ;
Ardissino, Diego ;
Montalescot, Gilles ;
Aylward, Philip ;
Magnani, Giulia ;
Jensen, Eva C. ;
Held, Peter ;
Braunwald, Eugene ;
Sabatine, Marc S. .
EUROPEAN HEART JOURNAL, 2016, 37 (14) :1133-1142
[5]   THE MEGAKARYOCYTE PLATELET SYSTEM AND VASCULAR-DISEASE [J].
BROWN, AS ;
MARTIN, JF .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 :9-15
[6]   Reticulated platelets and immature platelet fraction: Clinical applications and method limitations [J].
Buttarello, Mauro ;
Mezzapelle, Giacomo ;
Freguglia, Francesca ;
Plebani, Mario .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (04) :363-370
[7]   Assessment of an immature platelet fraction (IFP%) in the diagnosis of thrombocytopenia [J].
Cannavo, Isabelle ;
Ferrero-Vacher, Corinne ;
Sudaka, Isabelle ;
Aquaronne, Danielle ;
Berthier, Frederic ;
Raynaud, Sophie .
ANNALES DE BIOLOGIE CLINIQUE, 2010, 68 (04) :415-420
[8]  
Cesari F, 2008, THROMB HAEMOSTASIS, V99, P930, DOI [10.1160/TH08-01-0002, 10.1160/THOS-01-0002]
[9]   Reticulated platelets predict cardiovascular death in acute coronary syndrome patients Insights from the AMI-Florence 2 Study [J].
Cesari, Francesca ;
Marcucci, Rossella ;
Gori, Anna Maria ;
Caporale, Roberto ;
Fanelli, Alessandra ;
Casola, Giulia ;
Balzi, Daniela ;
Barchielli, Alessandro ;
Valente, Serafina ;
Giglioli, Cristina ;
Gensini, Gian Franco ;
Abbate, Rosanna .
THROMBOSIS AND HAEMOSTASIS, 2013, 109 (05) :846-853
[10]   Utility of Cardiac Biomarkers in Predicting Infarct Size, Left Ventricular Function, and Clinical Outcome After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction [J].
Chia, Stanley ;
Senatore, Fred ;
Raffel, O. Christopher ;
Lee, Hang ;
Wackers, Frans J. Th. ;
Jang, Ik-Kyung .
JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (04) :415-423